Literature DB >> 17261487

Academic and educational outcomes of children with ADHD.

Irene M Loe1, Heidi M Feldman.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is associated with poor grades, poor reading and math standardized test scores, and increased grade retention. ADHD is also associated with increased use of school-based services, increased rates of detention and expulsion, and ultimately with relatively low rates of high school graduation and postsecondary education. Children in community samples who show symptoms of inattention, hyperactivity, and impulsivity with or without formal diagnoses of ADHD also show poor academic and educational outcomes. Pharmacologic treatment and behavior management are associated with reduction of the core symptoms of ADHD and increased academic productivity, but not with improved standardized test scores or ultimate educational attainment. Future research must use conceptually based outcome measures in prospective, longitudinal, and community-based studies to determine which pharmacologic, behavioral, and educational interventions can improve academic and educational outcomes of children with ADHD.

Entities:  

Mesh:

Year:  2007        PMID: 17261487     DOI: 10.1016/j.ambp.2006.05.005

Source DB:  PubMed          Journal:  Ambul Pediatr        ISSN: 1530-1567


  46 in total

Review 1.  Parental preferences and goals regarding ADHD treatment.

Authors:  Alexander G Fiks; Stephanie Mayne; Elena Debartolo; Thomas J Power; James P Guevara
Journal:  Pediatrics       Date:  2013-09-02       Impact factor: 7.124

2.  EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood.

Authors:  Madeline M Robertson; Sarah Furlong; Bradley Voytek; Thomas Donoghue; Charlotte A Boettiger; Margaret A Sheridan
Journal:  J Neurophysiol       Date:  2019-10-16       Impact factor: 2.714

3.  Association of Behavior in Boys From Low Socioeconomic Neighborhoods With Employment Earnings in Adulthood.

Authors:  Francis Vergunst; Richard E Tremblay; Daniel Nagin; Yann Algan; Elizabeth Beasley; Jungwee Park; Cedric Galera; Frank Vitaro; Sylvana M Côté
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

4.  Shared decision-making in pediatrics: a national perspective.

Authors:  Alexander G Fiks; A Russell Localio; Evaline A Alessandrini; David A Asch; James P Guevara
Journal:  Pediatrics       Date:  2010-07-12       Impact factor: 7.124

5.  Receiving treatment for attention-deficit hyperactivity disorder: do the perspectives of adolescents matter?

Authors:  Regina Bussing; Bonnie T Zima; Dana M Mason; Phillip C Porter; Cynthia W Garvan
Journal:  J Adolesc Health       Date:  2010-10-20       Impact factor: 5.012

6.  Psychopathology and Related Psychosocial Factors in Children with Office Discipline Referrals at School: Evidence from a Developing Country.

Authors:  İbrahim Selçuk Esin; Onur Burak Dursun; Hamit Acemoğlu; Burak Baykara
Journal:  Community Ment Health J       Date:  2015-04-01

7.  Are There Executive Dysfunction Subtypes Within ADHD?

Authors:  Bethan A Roberts; Michelle M Martel; Joel T Nigg
Journal:  J Atten Disord       Date:  2016-07-28       Impact factor: 3.256

8.  Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder.

Authors:  Alexander G Fiks; Stephanie Mayne; Cayce C Hughes; Elena Debartolo; Carina Behrens; James P Guevara; Thomas Power
Journal:  Acad Pediatr       Date:  2012-06-28       Impact factor: 3.107

Review 9.  Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise Review.

Authors:  Khyati Brahmbhatt; Donald M Hilty; Mina Hah; Jaesu Han; Kathy Angkustsiri; Julie B Schweitzer
Journal:  J Adolesc Health       Date:  2016-05-18       Impact factor: 5.012

10.  Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Sören Schmidt; Franz Petermann
Journal:  BMC Psychiatry       Date:  2009-09-17       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.